Clinical Trials
4
Active:0
Completed:4
Trial Phases
1 Phases
Phase 2:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 2
4 (100.0%)Efficacy and Safety of Fispemifene in the Treatment of Hypogonadal Men With Chronic Obstructive Pulmonary Disease That Are on Oral Glucocorticoid Therapy
Phase 2
Completed
- Conditions
- HypogonadismChronic Obstructive Pulmonary Disease
- First Posted Date
- 2010-02-03
- Last Posted Date
- 2010-02-03
- Lead Sponsor
- QuatRx Pharmaceuticals Company
- Target Recruit Count
- 15
- Registration Number
- NCT01061970
Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 Inhibitors
Phase 2
Completed
- Conditions
- HypogonadismErectile Dysfunction
- First Posted Date
- 2006-12-25
- Last Posted Date
- 2010-02-03
- Lead Sponsor
- QuatRx Pharmaceuticals Company
- Target Recruit Count
- 72
- Registration Number
- NCT00415571
- Locations
- 🇺🇸
Radiant Research, San Antonio, Texas, United States
🇺🇸Genova Clinical Research, Tucson, Arizona, United States
🇺🇸HealthStar Research, Hot Springs, Arkansas, United States
Safety and Efficacy Study of Two Dose Regimens of Becocalcidiol in the Treatment of Plaque-Type Psoriasis
Phase 2
Completed
- Conditions
- Psoriasis
- First Posted Date
- 2006-09-08
- Last Posted Date
- 2006-09-08
- Lead Sponsor
- QuatRx Pharmaceuticals Company
- Target Recruit Count
- 150
- Registration Number
- NCT00373516
- Locations
- 🇺🇸
Clinical Research Site, San Antonio, Texas, United States
A Preliminary Clinical Study to Evaluate Fispemifene in the Treatment of Hypogonadism
Phase 2
Completed
- Conditions
- Hypogonadism
- First Posted Date
- 2006-02-10
- Last Posted Date
- 2008-03-03
- Lead Sponsor
- QuatRx Pharmaceuticals Company
- Target Recruit Count
- 100
- Registration Number
- NCT00290134
- Locations
- 🇺🇸
Clinical Research Site, Seattle, Washington, United States
News
No news found